|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Tsumura_&_Co.
Kowa Company, Ltd.
|
|
gptkbp:CEO
|
gptkb:Katsuhiko_Taisho
|
|
gptkbp:employees
|
Approximately 3,000
|
|
gptkbp:founded
|
1912
|
|
gptkbp:founder
|
gptkb:Taisho_Pharmaceutical_Co.,_Ltd.
|
|
gptkbp:headquarters
|
gptkb:Tokyo,_Japan
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Taisho Pharmaceutical Co., Ltd.
|
|
gptkbp:market
|
gptkb:Asia
gptkb:Japan
gptkb:North_America
Europe
|
|
gptkbp:notableEvent
|
gptkb:Taisho_Seiyaku
gptkb:Daiichi_Seiyaku
gptkb:Taisho_Health_Science
Colac
Soflan
Pabron
Taisho_Pharmaceutical_Co.,_Ltd._products
|
|
gptkbp:partnerships
|
gptkb:Mitsubishi_Tanabe_Pharma_Corporation
gptkb:Kirin_Holdings_Company,_Limited
|
|
gptkbp:products
|
Prescription drugs
Health supplements
Over-the-counter drugs
|
|
gptkbp:researchFocus
|
Nutraceuticals
Prescription medications
OTC medications
|
|
gptkbp:revenue
|
¥100 billion (approx.)
|
|
gptkbp:stockExchange
|
gptkb:Tokyo_Stock_Exchange
|
|
gptkbp:stockSymbol
|
4581
|
|
gptkbp:subsidiary
|
gptkb:Taisho_Pharmaceutical_(Thailand)_Co.,_Ltd.
gptkb:Taisho_Pharmaceutical_(USA)_Inc.
|
|
gptkbp:type
|
Public company
|
|
gptkbp:website
|
www.taisho.co.jp
|